J. Dawes

Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidates

Mohammad M. Karimi, Bruce J. Bolt, Juan J. Caceres, 2018, Nature Communications.

LUMI-PCR: an Illumina platform ligation-mediated PCR protocol for integration site cloning, provides molecular quantitation of integration sites

Juan J. Caceres, Alberto Paccanaro, L. Game, 2020, Mobile DNA.

Tracking Subclonal Mutation Frequencies Throughout Lymphomagenesis Identifies Cancer Drivers in Mouse Models of Lymphoma

Juan J. Caceres, A. Paccanaro, K. Naresh, 2017, bioRxiv.

Forward and Reverse Genetics of B Cell Malignancies: From Insertional Mutagenesis to CRISPR-Cas

A. Uren, J. Dawes, Joanna C. Dawes, 2021, Frontiers in Immunology.

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer

N. Tunariu, W. Brugger, D. Talbot, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidates

Juan J. Caceres, Alberto Paccanaro, K. Naresh, 2018, Nature Communications.

Results from the biomarker-driven basket trial of RO5126766 (CH5127566), a potent RAF/MEK inhibitor, in RAS- or RAF-mutated malignancies including multiple myeloma.

N. Tunariu, Juanita Lopez, U. Banerji, 2017 .